Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
Clinical trial NCT03844997 · COMPLETED
Trial details
- NCT number
- NCT03844997
- Sponsor
- Sudipto Mukherjee, MD, PhD, MPH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2024-01-24
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.